Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 1|pp. 285–298
MAGE-A11 is a potential prognostic biomarker and immunotherapeutic target in gastric cancer
Back to articleFigure 9(9 of 12)
100%
Figure 9
Figure 9.Violin plot of MAGE-A11 expression and sensitivity to immunotherapy. (A) Anti-PD1 immunotherapy. (B) Anti-CTLA4 immunotherapy. (C) Anti-PD1 and CTLA4 immunotherapy. (D) Non-immunotherapy.